ID PE2R1_HUMAN Reviewed; 402 AA. AC P34995; Q5U5U4; Q86UH3; Q86VB5; Q8NHB2; DT 01-FEB-1994, integrated into UniProtKB/Swiss-Prot. DT 10-MAY-2005, sequence version 3. DT 24-JAN-2024, entry version 181. DE RecName: Full=Prostaglandin E2 receptor EP1 subtype; DE Short=PGE receptor EP1 subtype; DE Short=PGE2 receptor EP1 subtype; DE AltName: Full=Prostanoid EP1 receptor; GN Name=PTGER1; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT THR-71. RX PubMed=8253813; DOI=10.1016/s0021-9258(19)74379-8; RA Funk C.D., Furci L., Fitzgerald G.A., Grygorczyk R., Rochette C., RA Bayne M.A., Abramovitz M., Adam M., Metters K.M.; RT "Cloning and expression of a cDNA for the human prostaglandin E receptor RT EP1 subtype."; RL J. Biol. Chem. 268:26767-26772(1993). RN [2] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RA Suwa M., Sato T., Okouchi I., Arita M., Futami K., Matsumoto S., RA Tsutsumi S., Aburatani H., Asai K., Akiyama Y.; RT "Genome-wide discovery and analysis of human seven transmembrane helix RT receptor genes."; RL Submitted (JUL-2001) to the EMBL/GenBank/DDBJ databases. RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT THR-71. RC TISSUE=Kidney; RA Warren C.N., Aronstam R.S., Sharma S.V.; RT "cDNA clones of human proteins involved in signal transduction sequenced by RT the Guthrie cDNA resource center (www.cdna.org)."; RL Submitted (APR-2003) to the EMBL/GenBank/DDBJ databases. RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Ovary, and Pancreas; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). CC -!- FUNCTION: Receptor for prostaglandin E2 (PGE2). The activity of this CC receptor is mediated by G(q) proteins which activate a CC phosphatidylinositol-calcium second messenger system. May play a role CC as an important modulator of renal function. Implicated the smooth CC muscle contractile response to PGE2 in various tissues. CC -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein. CC -!- TISSUE SPECIFICITY: Abundant in kidney. Lower level expression in lung, CC skeletal muscle and spleen, lowest expression in testis and not CC detected in liver brain and heart. CC -!- PTM: Phosphorylated. {ECO:0000305}. CC -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family. CC {ECO:0000255|PROSITE-ProRule:PRU00521}. CC -!- SEQUENCE CAUTION: CC Sequence=BAC05723.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305}; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; L22647; AAC37539.1; -; mRNA. DR EMBL; AB065464; BAC05723.1; ALT_SEQ; Genomic_DNA. DR EMBL; AY275470; AAP32302.1; -; mRNA. DR EMBL; BC039034; AAH39034.1; -; mRNA. DR EMBL; BC051286; AAH51286.1; -; mRNA. DR CCDS; CCDS12309.1; -. DR PIR; A49690; A49690. DR RefSeq; NP_000946.2; NM_000955.2. DR AlphaFoldDB; P34995; -. DR SMR; P34995; -. DR BioGRID; 111703; 4. DR STRING; 9606.ENSP00000292513; -. DR BindingDB; P34995; -. DR ChEMBL; CHEMBL1811; -. DR DrugBank; DB00770; Alprostadil. DR DrugBank; DB00905; Bimatoprost. DR DrugBank; DB00297; Bupivacaine. DR DrugBank; DB00429; Carboprost tromethamine. DR DrugBank; DB00917; Dinoprostone. DR DrugBank; DB01088; Iloprost. DR DrugBank; DB09211; Limaprost. DR DrugBank; DB00929; Misoprostol. DR DrugBank; DB15071; Omidenepag isopropyl. DR DrugBank; DB16315; Rivenprost. DR DrugBank; DB04297; Trichostatin A. DR DrugCentral; P34995; -. DR GuidetoPHARMACOLOGY; 340; -. DR TCDB; 9.A.14.9.1; the g-protein-coupled receptor (gpcr) family. DR GlyCosmos; P34995; 2 sites, No reported glycans. DR GlyGen; P34995; 2 sites. DR PhosphoSitePlus; P34995; -. DR BioMuta; PTGER1; -. DR DMDM; 83287886; -. DR PaxDb; 9606-ENSP00000292513; -. DR PeptideAtlas; P34995; -. DR Antibodypedia; 13701; 313 antibodies from 32 providers. DR DNASU; 5731; -. DR Ensembl; ENST00000292513.4; ENSP00000292513.3; ENSG00000160951.4. DR GeneID; 5731; -. DR KEGG; hsa:5731; -. DR MANE-Select; ENST00000292513.4; ENSP00000292513.3; NM_000955.3; NP_000946.2. DR UCSC; uc002mys.3; human. DR AGR; HGNC:9593; -. DR CTD; 5731; -. DR DisGeNET; 5731; -. DR GeneCards; PTGER1; -. DR HGNC; HGNC:9593; PTGER1. DR HPA; ENSG00000160951; Tissue enriched (kidney). DR MIM; 176802; gene. DR neXtProt; NX_P34995; -. DR OpenTargets; ENSG00000160951; -. DR PharmGKB; PA286; -. DR VEuPathDB; HostDB:ENSG00000160951; -. DR eggNOG; KOG3656; Eukaryota. DR GeneTree; ENSGT01030000234559; -. DR HOGENOM; CLU_045991_3_0_1; -. DR InParanoid; P34995; -. DR OMA; IYLIAKC; -. DR OrthoDB; 4642085at2759; -. DR PhylomeDB; P34995; -. DR TreeFam; TF324982; -. DR PathwayCommons; P34995; -. DR Reactome; R-HSA-391908; Prostanoid ligand receptors. DR Reactome; R-HSA-416476; G alpha (q) signalling events. DR SignaLink; P34995; -. DR SIGNOR; P34995; -. DR BioGRID-ORCS; 5731; 12 hits in 1156 CRISPR screens. DR GeneWiki; EP1_receptor; -. DR GenomeRNAi; 5731; -. DR Pharos; P34995; Tclin. DR PRO; PR:P34995; -. DR Proteomes; UP000005640; Chromosome 19. DR RNAct; P34995; Protein. DR Bgee; ENSG00000160951; Expressed in metanephros cortex and 96 other cell types or tissues. DR GO; GO:0005886; C:plasma membrane; IBA:GO_Central. DR GO; GO:0031748; F:D1 dopamine receptor binding; IEA:Ensembl. DR GO; GO:0004957; F:prostaglandin E receptor activity; IBA:GO_Central. DR GO; GO:0007191; P:adenylate cyclase-activating dopamine receptor signaling pathway; IEA:Ensembl. DR GO; GO:0007189; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; IBA:GO_Central. DR GO; GO:0007186; P:G protein-coupled receptor signaling pathway; TAS:ProtInc. DR GO; GO:0006954; P:inflammatory response; IBA:GO_Central. DR GO; GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IBA:GO_Central. DR GO; GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl. DR Gene3D; 1.20.1070.10; Rhodopsin 7-helix transmembrane proteins; 1. DR InterPro; IPR000276; GPCR_Rhodpsn. DR InterPro; IPR017452; GPCR_Rhodpsn_7TM. DR InterPro; IPR008365; Prostanoid_rcpt. DR InterPro; IPR001244; Prostglndn_DP_rcpt. DR InterPro; IPR000708; Prostglndn_EP1_rcpt. DR PANTHER; PTHR11866; G-PROTEIN COUPLED RECEPTOR FAMILY 1 MEMBER; 1. DR PANTHER; PTHR11866:SF3; PROSTAGLANDIN E2 RECEPTOR EP1 SUBTYPE; 1. DR Pfam; PF00001; 7tm_1; 1. DR PRINTS; PR00428; PROSTAGLNDNR. DR PRINTS; PR01788; PROSTANOIDR. DR PRINTS; PR00580; PRSTNOIDEP1R. DR SUPFAM; SSF81321; Family A G protein-coupled receptor-like; 1. DR PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1. DR PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1. DR Genevisible; P34995; HS. PE 2: Evidence at transcript level; KW Cell membrane; Disulfide bond; G-protein coupled receptor; Glycoprotein; KW Membrane; Phosphoprotein; Receptor; Reference proteome; Transducer; KW Transmembrane; Transmembrane helix. FT CHAIN 1..402 FT /note="Prostaglandin E2 receptor EP1 subtype" FT /id="PRO_0000070050" FT TOPO_DOM 1..35 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 36..62 FT /note="Helical; Name=1" FT /evidence="ECO:0000255" FT TOPO_DOM 63..72 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 73..96 FT /note="Helical; Name=2" FT /evidence="ECO:0000255" FT TOPO_DOM 97..111 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 112..133 FT /note="Helical; Name=3" FT /evidence="ECO:0000255" FT TOPO_DOM 134..155 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 156..177 FT /note="Helical; Name=4" FT /evidence="ECO:0000255" FT TOPO_DOM 178..201 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 202..227 FT /note="Helical; Name=5" FT /evidence="ECO:0000255" FT TOPO_DOM 228..294 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 295..321 FT /note="Helical; Name=6" FT /evidence="ECO:0000255" FT TOPO_DOM 322..332 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 333..354 FT /note="Helical; Name=7" FT /evidence="ECO:0000255" FT TOPO_DOM 355..402 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT REGION 238..266 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT CARBOHYD 8 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 25 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT DISULFID 110..188 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00521" FT VARIANT 71 FT /note="A -> T (in dbSNP:rs1057362)" FT /evidence="ECO:0000269|PubMed:8253813, ECO:0000269|Ref.3" FT /id="VAR_017190" FT VARIANT 223 FT /note="T -> M (in dbSNP:rs28364042)" FT /id="VAR_029216" FT VARIANT 256 FT /note="H -> R (in dbSNP:rs7249305)" FT /id="VAR_029217" FT CONFLICT 230 FT /note="L -> H (in Ref. 1; AAC37539)" FT /evidence="ECO:0000305" SQ SEQUENCE 402 AA; 41801 MW; B925359ABD86880C CRC64; MSPCGPLNLS LAGEATTCAA PWVPNTSAVP PSGASPALPI FSMTLGAVSN LLALALLAQA AGRLRRRRSA ATFLLFVASL LATDLAGHVI PGALVLRLYT AGRAPAGGAC HFLGGCMVFF GLCPLLLGCG MAVERCVGVT RPLLHAARVS VARARLALAA VAAVALAVAL LPLARVGRYE LQYPGTWCFI GLGPPGGWRQ ALLAGLFASL GLVALLAALV CNTLSGLALL RARWRRRSRR PPPASGPDSR RRWGAHGPRS ASASSASSIA SASTFFGGSR SSGSARRARA HDVEMVGQLV GIMVVSCICW SPMLVLVALA VGGWSSTSLQ RPLFLAVRLA SWNQILDPWV YILLRQAVLR QLLRLLPPRA GAKGGPAGLG LTPSAWEASS LRSSRHSGLS HF //